Neoprobe's newly licensed radiopharmaceutical imaging agent, AZD4694, is a fluorine-18 labeled radioligand for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer's disease.
Recent stories on Highlight HEALTH 2.0
Stories tagged: amyloid plaque
Neoprobe Imaging Agent Aids in Diagnosis of Alzheimer’s Disease
by Walter Jessen, Ph.D. on Tuesday, December 13, 2011
(1 votes, average: 5.00 out of 5)
Loading ...
Print Post
Like this article? Highlight HEALTH 2.0 delivers weekly articles on new ideas impacting health and medicine. Join the community by subscribing (more).
Got a health news tip or pitch?
Highlight HEALTH 2.0 Channels
Subscribe
Monthly Top Stories
- N/A
Recent News on Highlight HEALTH
- Eating More Fiber May Lower Risk of Stroke
May 21st, 2013 - American Urology Association Changes Position on Routine Prostate Testing
May 07th, 2013 - Study Finds that Fluoride Reduces Adhesion of Bacteria on Teeth
May 02nd, 2013 - Researchers Find Multiple Genes that Contribute to Schizophrenia Risk
April 19th, 2013 - Good Bacteria Associated with Acne-free Skin
April 10th, 2013
